Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreERT2 lines
Publication type: Journal Article
Publication date: 2019-10-22
scimago Q1
wos Q3
SJR: 0.575
CiteScore: 5.9
Impact factor: 2.0
ISSN: 09628819, 15739368
PubMed ID:
31641921
Genetics
Biotechnology
Agronomy and Crop Science
Animal Science and Zoology
Abstract
The CreERT2/loxP system is widely used to induce conditional gene deletion in mice. One of the main advantages of the system is that Cre-mediated recombination can be controlled in time through Tamoxifen administration. This has allowed researchers to study the function of embryonic lethal genes at later developmental timepoints. In addition, CreERT2 mouse lines are commonly used in combination with reporter genes for lineage tracing and mosaic analysis. In order for these experiments to be reliable, it is crucial that the cell labeling approach only marks the desired cell population and their progeny, as unfaithful expression of reporter genes in other cell types or even unintended labeling of the correct cell population at an undesired time point could lead to wrong conclusions. Here we report that all CreERT2 mouse lines that we have studied exhibit a certain degree of Tamoxifen-independent, basal, Cre activity. Using Ai14 and Ai3, two commonly used fluorescent reporter genes, we show that those basal Cre activity levels are sufficient to label a significant amount of cells in a variety of tissues during embryogenesis, postnatal development and adulthood. This unintended labelling of cells imposes a serious problem for lineage tracing and mosaic analysis experiments. Importantly, however, we find that reporter constructs differ greatly in their susceptibility to basal CreERT2 activity. While Ai14 and Ai3 easily recombine under basal CreERT2 activity levels, mTmG and R26R-EYFP rarely become activated under these conditions and are therefore better suited for cell tracking experiments.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
|
|
|
Arteriosclerosis, Thrombosis, and Vascular Biology
4 publications, 4.76%
|
|
|
Nature Communications
3 publications, 3.57%
|
|
|
iScience
3 publications, 3.57%
|
|
|
JCI insight
2 publications, 2.38%
|
|
|
bioRxiv
2 publications, 2.38%
|
|
|
Developmental Biology
2 publications, 2.38%
|
|
|
Cell Reports
2 publications, 2.38%
|
|
|
Vascular Pharmacology
2 publications, 2.38%
|
|
|
Development (Cambridge)
1 publication, 1.19%
|
|
|
Current Opinion in Hematology
1 publication, 1.19%
|
|
|
Journal of Cardiovascular Development and Disease
1 publication, 1.19%
|
|
|
Frontiers in Immunology
1 publication, 1.19%
|
|
|
Frontiers in Molecular Neuroscience
1 publication, 1.19%
|
|
|
Cancers
1 publication, 1.19%
|
|
|
Angiogenesis
1 publication, 1.19%
|
|
|
Nature Reviews Cardiology
1 publication, 1.19%
|
|
|
Nature Cardiovascular Research
1 publication, 1.19%
|
|
|
Bone
1 publication, 1.19%
|
|
|
Brain, Behavior, and Immunity
1 publication, 1.19%
|
|
|
Stem Cell Research and Therapy
1 publication, 1.19%
|
|
|
Cellular and Molecular Life Sciences
1 publication, 1.19%
|
|
|
Atherosclerosis Plus
1 publication, 1.19%
|
|
|
Journal of Hepatology
1 publication, 1.19%
|
|
|
Neuroscience
1 publication, 1.19%
|
|
|
Experimental Eye Research
1 publication, 1.19%
|
|
|
Methods
1 publication, 1.19%
|
|
|
Neuron
1 publication, 1.19%
|
|
|
European Journal of Immunology
1 publication, 1.19%
|
|
|
Journal of Comparative Neurology
1 publication, 1.19%
|
|
|
1
2
3
4
|
Publishers
|
5
10
15
20
25
|
|
|
Elsevier
23 publications, 27.38%
|
|
|
Cold Spring Harbor Laboratory
14 publications, 16.67%
|
|
|
Springer Nature
12 publications, 14.29%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
6 publications, 7.14%
|
|
|
Wiley
6 publications, 7.14%
|
|
|
MDPI
3 publications, 3.57%
|
|
|
American Physiological Society
3 publications, 3.57%
|
|
|
American Society for Clinical Investigation
3 publications, 3.57%
|
|
|
Frontiers Media S.A.
2 publications, 2.38%
|
|
|
S. Karger AG
2 publications, 2.38%
|
|
|
The Company of Biologists
1 publication, 1.19%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 1.19%
|
|
|
Pleiades Publishing
1 publication, 1.19%
|
|
|
Rockefeller University Press
1 publication, 1.19%
|
|
|
Oxford University Press
1 publication, 1.19%
|
|
|
Hindawi Limited
1 publication, 1.19%
|
|
|
eLife Sciences Publications
1 publication, 1.19%
|
|
|
Annual Reviews
1 publication, 1.19%
|
|
|
Society for Neuroscience
1 publication, 1.19%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
84
Total citations:
84
Citations from 2024:
24
(28.57%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Álvarez Aznar A. et al. Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreERT2 lines // Transgenic Research. 2019. Vol. 29. No. 1. pp. 53-68.
GOST all authors (up to 50)
Copy
Álvarez Aznar A., Martínez Corral I., Daubel N., Betsholtz C., Mäkinen T., Gaengel K. Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreERT2 lines // Transgenic Research. 2019. Vol. 29. No. 1. pp. 53-68.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1007/s11248-019-00177-8
UR - https://doi.org/10.1007/s11248-019-00177-8
TI - Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreERT2 lines
T2 - Transgenic Research
AU - Álvarez Aznar, A
AU - Martínez Corral, I
AU - Daubel, N
AU - Betsholtz, C.
AU - Mäkinen, T.
AU - Gaengel, Konstantin
PY - 2019
DA - 2019/10/22
PB - Springer Nature
SP - 53-68
IS - 1
VL - 29
PMID - 31641921
SN - 0962-8819
SN - 1573-9368
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2019_Álvarez Aznar,
author = {A Álvarez Aznar and I Martínez Corral and N Daubel and C. Betsholtz and T. Mäkinen and Konstantin Gaengel},
title = {Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreERT2 lines},
journal = {Transgenic Research},
year = {2019},
volume = {29},
publisher = {Springer Nature},
month = {oct},
url = {https://doi.org/10.1007/s11248-019-00177-8},
number = {1},
pages = {53--68},
doi = {10.1007/s11248-019-00177-8}
}
Cite this
MLA
Copy
Álvarez Aznar, A., et al. “Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreERT2 lines.” Transgenic Research, vol. 29, no. 1, Oct. 2019, pp. 53-68. https://doi.org/10.1007/s11248-019-00177-8.